Literature DB >> 10871326

Multiple cellular mechanisms mediate the effect of lobeline on the release of norepinephrine.

E Sántha1, B Sperlágh, T Zelles, G Zsilla, P T Tóth, B Lendvai, M Baranyi, E S Vizi.   

Abstract

The complex effect of lobeline on [(3)H]norepinephrine ([(3)H]NE) release was investigated in this study. Lobeline-induced release of [(3)H]NE from the vas deferens was strictly concentration-dependent. In contrast, electrical stimulation-evoked release was characterized by diverse effects of lobeline depending on the concentration used: at lower concentration (10 microM), it increased the release and at high concentration (100 and 300 microM), the evoked release of [(3)H]NE was abolished. The effect of lobeline on the basal release was [Ca(2+)]-independent, insensitive to mecamylamine, a nicotinic acetylcholine receptor antagonist, and to desipramine, a noradrenaline uptake inhibitor. However, lobeline-induced release was temperature-dependent: at low temperature (12 degrees C), at which the membrane carrier proteins are inhibited, lobeline failed to increase the basal release. Lobeline dose dependently inhibited the uptake of [(3)H]NE into rat hippocampal synaptic vesicles and purified synaptosomes with IC(50) values of 1.19 +/- 0.11 and 6.53 +/- 1.37 microM, respectively. Lobeline also inhibited Ca(2+) influx induced by KCl depolarization in sympathetic neurons measured with the Fura-2 technique. In addition, phenylephrine, an alpha(1)-adrenoceptor agonist, contracted the smooth muscle of the vas deferens and enhanced stimulation-evoked contraction. Both effects were inhibited by lobeline. Our results can be best explained as a reversal of the monoamine uptake by lobeline that is facilitated by the increased intracellular NE level after lobeline blocks vesicular uptake. At high concentrations, lobeline acts as a nonselective Ca(2+) channel antagonist blocking pre- and postjunctional Ca(2+) channels serving as a counterbalance for the multiple transmitter releasing actions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10871326

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  5 in total

1.  Distinct mechanisms underlying alpha1-adrenoceptor and P2x purinoceptor operated ATP release and contraction in the guinea-pig vas deferens.

Authors:  B Sperlágh; P Illes; Z Gerevich; A Köfalvi
Journal:  Neurochem Res       Date:  2001-09       Impact factor: 3.996

2.  Lobeline attenuates neonatal ethanol-mediated changes in hyperactivity and dopamine transporter function in the prefrontal cortex in rats.

Authors:  A M Smith; K A Wellmann; T M Lundblad; M L Carter; S Barron; L P Dwoskin
Journal:  Neuroscience       Date:  2011-11-20       Impact factor: 3.590

3.  Differential effect of nicotinic agonists on the [3H]norepinephrine release from rat hippocampal slices.

Authors:  J P Kiss; K Windisch; K De Oliveira; E C Hennings; A Mike; B K Szász
Journal:  Neurochem Res       Date:  2001-09       Impact factor: 3.996

Review 4.  The potential of sarcospan in adhesion complex replacement therapeutics for the treatment of muscular dystrophy.

Authors:  Jamie L Marshall; Yukwah Kwok; Brian J McMorran; Linda G Baum; Rachelle H Crosbie-Watson
Journal:  FEBS J       Date:  2013-05-13       Impact factor: 5.542

5.  High throughput screening for compounds that alter muscle cell glycosylation identifies new role for N-glycans in regulating sarcolemmal protein abundance and laminin binding.

Authors:  Paula V Cabrera; Mabel Pang; Jamie L Marshall; Raymond Kung; Stanley F Nelson; Stephanie H Stalnaker; Lance Wells; Rachelle H Crosbie-Watson; Linda G Baum
Journal:  J Biol Chem       Date:  2012-05-08       Impact factor: 5.157

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.